Department of Medicinal Chemistry and Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
J Med Chem. 2013 Mar 28;56(6):2415-28. doi: 10.1021/jm301757v. Epub 2013 Mar 18.
To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the Vmax of substrate hydrolysis without influencing the KM. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric site. Fluorescence studies showed a sigmoidal binding profile indicating highly cooperative binding. Competition with a positively charged, heparin-binding polymer did not fully nullify inhibition suggesting importance of hydrophobic forces to binding. This discovery suggests the operation of a dual-element recognition process, which relies on an initial Coulombic attraction of anionic SAMs to the cationic HBS of FXIa that forms a locked complex through tight interaction with an adjacent hydrophobic patch. The dual-element strategy may be widely applicable for discovering SAMs of other GBPs.
为了发现有前景的糖胺聚糖结合蛋白 (GBPs) 的硫酸化变构调节剂 (SAM),例如人凝血因子 XIa (FXIa),我们筛选了 26 种合成的磺化喹唑啉-4(3H)-酮 (QAO) 文库,结果鉴定出了 6 种分子,它们在不影响 KM 的情况下降低了底物水解的 Vmax。FXIa 肝素结合位点 (HBS) 残基的突变导致抑制效力降低近 5 倍,支持变构结合位点的识别。荧光研究显示出明显的 S 型结合曲线,表明高度协同的结合。与带正电荷的肝素结合聚合物的竞争并未完全消除抑制作用,这表明疏水作用力对结合很重要。这一发现表明存在双元件识别过程,该过程依赖于阴离子 SAM 与 FXIa 的阳离子 HBS 的初始库仑吸引力,该吸引力通过与相邻的疏水性斑块的紧密相互作用形成锁定复合物。双元件策略可能广泛适用于发现其他 GBPs 的 SAM。